DUBLIN, July 11, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Worldwide Pediatric Vaccines Market: Doses, Immunization, Cases, Forecast, and Analysis" report to their offering.
Global Pediatric Vaccines Market is expected to cross US$ 40 Billion by the year 2022
The market of Combos (Combination vaccines) is thriving as most of the parents believed that if all these vaccines were given separately, than each child would have to take a large number of injections.
This research found that around 500 million infants get immunization by the year 2022 owing to rising concern against vaccine-preventable diseases and growing awareness. This report covers the past and present scenario and the growth prospects of the infants' vaccine (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Polio, Haemophilus influenzae type B, Rotavirus, Varicella, Combination) Vaccines market across the world for the period of 2011-2022.
This study indicates that that around the globe nearly 600 million doses of vaccines will be administrated in infants by the year 2022 which will be nearly five times the number of influenza doses administered. The number of DTap doses administered in infants is forecast to increase over the years and will cross 50 Million by the year 2022.
Report covers detailed information on all the 11 vaccines (Pneumococcal, Rotavirus, Meningococcal, DTap, MMR, Polio, Hepatitis, Varicella, Haemophilus influenzae type B, Influenza, Combination) Vaccines Doses of Vaccines Administered and Forecast.
'Worldwide Pediatric Vaccines Market: Doses, Immunization, Cases, Forecast, and Analysis' is the 2nd edition report on Pediatric Vaccines. This 199 page market research report with 93 Figures and 30 Tables provides data and analysis on Global Pediatric Vaccines Market, Infants Immunized, Number of Vaccine Doses Administered in Pediatric (Infant) (Disease wise) & Key Players.
Vaccine Has Been Extensively Studied From 3 Major Points:
1. Global Pediatric (Infant) Vaccines (Disease wise) Market & Forecast (2011 - 2022)
2. Pediatric (Infants) Immunized (Disease wise) & Forecast (2011 - 2022)
3. Doses of Vaccines Administered in Pediatric (Infant) (Disease wise) & Forecast (2011 - 2022)
11 Vaccines Studied in the Report are as Follows:
2. MMR (Measles, Mumps, and Rubella)
6. DTap (Diphtheria, Tetanus, Pertussis)
7. Haemophilus influenzae type B
11. Combination Vaccine
Companies Vaccines Sales and Forecast:
1. GlaxoSmithKline, plc Sales & Forecast (2011 - 2022)
2. Merck & Co. Sales & Forecast (2011 - 2022)
3. Sanofi Pasteur's Sales & Forecast (2011 - 2022)
4. Pfizer, Inc.'s Sales & Forecast (2011 - 2022)
5. Others Vaccines
For more information about this report visit
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets